Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

• Sara Tartof ,

  * E-mail: startof@gmail.com

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Amanda Cohn,

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Félix Tarbangdo,

  Affiliation Direction de la Lutte Contre la Maladie, Ministère de la Santé, Ouagadougou, Burkina Faso

  ⨯
• Mamoudou H. Djingarey,

  Affiliation Intercountry Support Team for West Africa, World Health Organization, Ouagadougou, Burkina Faso

  ⨯
• Nancy Messonnier,

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Thomas A. Clark,

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Jean Ludovic Kambou,

  Affiliation Direction de la Lutte Contre la Maladie, Ministère de la Santé, Ouagadougou, Burkina Faso

  ⨯
• Ryan Novak,

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Fabien V. K. Diomandé,

  Affiliations Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, WHO Intercountry Support Team for West Africa, Ouagadougou, Burkina Faso

  ⨯
• Isaïe Medah,

  Affiliation Direction de la Lutte Contre la Maladie, Ministère de la Santé, Ouagadougou, Burkina Faso

  ⨯
• Michael L. Jackson

  Affiliation Group Health Research Institute, Group Health Cooperative, Seattle, Washington, United States of America

  ⨯